新興印刷(01975.HK)中期純利升84.77%至5086.8萬港元 中期息1.8港仙
格隆匯2月15日丨新興印刷(01975.HK)發佈公吿,截至2021年12月31日止六個月,實現收益3.59億港元,同比增長119.18%;公司股權持有人應占期內溢利5086.8萬港元,同比增長84.77%;基本及攤薄每股盈利10.60港仙;擬宣派中期股息1.8港仙。
公吿稱,收益增加主要由於部份客户重啟往年因新冠病毒COVID-19而延誤的重大及持續項目,同時該項目收益高過COVID-19病毒大流行之前的水平,令包裝及紙禮品套裝的印刷收益增加。此外,因部份東南亞地區採取的防疫措施不及中國的措施有效,令部份外國企業的生產線迴歸國內,也間接增進集團收到來自外國客户的銷售訂單。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.